Teva- Pharmaceutical Industries Profit Margin

As of the most recent data (June 2026), TEVA shows a profit margin of 4.08%. That compares with -0.95% in the prior-year period — up 529.1% year over year. That is below the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TEVA's profit margin is now 4.08% (was -0.95%) — a 529.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Teva- Pharmaceutical Industries is outperforming or lagging.

The Healthcare sector average profit margin is about 13.89%. Teva- Pharmaceutical Industries is at 4.08%, which is lower that average. That is roughly 70.6% below the sector mean. Use the comparison chart on this page to see how TEVA stacks up against individual peers as well.

That compares with -0.95% in the prior-year period — up 529.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Teva- Pharmaceutical Industries with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 4.08%) with ownership activity and broader fundamentals.